Article
High expression of RUNX1 in colorectal cancer subtype accelerates malignancy by inhibiting HMGCR
4 Jul 2024
Abstract excerpt
Colorectal cancer (CRC) presents a complex landscape, characterized by both inter-tumor and intra-tumor heterogeneity. RUNX1, a gene implicated in modulating tumor cell growth, survival, and differentiation, remains incompletely understood regarding its impact on CRC prognosis. In our investigation, we discerned a positive correlation between elevated RUNX1 expression and aggressive phenotypes across various CRC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
